Ligilactobacillus salivarius AR809 and its exopolysaccharides mitigate antibiotic-induced gut dysbiosis and restore intestinal barrier function
Gut microbiota dysbiosis is closely associated with intestinal barrier dysfunction and immune imbalance. This study evaluated the efficacy of Ligilactobacillus salivarius AR809 and its exopolysaccharides (EPS809) in alleviating dysbiosis-associated intestinal dysfunction. In an antibiotic-induced murine model, both...